U.S. markets closed

RAPT Therapeutics, Inc. (RAPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.15-0.70 (-3.71%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 2/14/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 30.28%
S&P500 52-Week Change 323.92%
52 Week High 341.86
52 Week Low 310.52
50-Day Moving Average 320.55
200-Day Moving Average 325.98

Share Statistics

Avg Vol (3 month) 3246.9k
Avg Vol (10 day) 3117.1k
Shares Outstanding 524.56M
Float 14.68M
% Held by Insiders 13.44%
% Held by Institutions 187.36%
Shares Short (Feb 11, 2021) 4976.76k
Short Ratio (Feb 11, 2021) 47.24
Short % of Float (Feb 11, 2021) 48.81%
Short % of Shares Outstanding (Feb 11, 2021) 43.98%
Shares Short (prior month Jan 14, 2021) 41.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-1,415.61%

Management Effectiveness

Return on Assets (ttm)-35.33%
Return on Equity (ttm)-66.41%

Income Statement

Revenue (ttm)3.74M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -51.77M
Net Income Avi to Common (ttm)-53.37M
Diluted EPS (ttm)-2.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)122.79M
Total Cash Per Share (mrq)5
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.05
Book Value Per Share (mrq)4.49

Cash Flow Statement

Operating Cash Flow (ttm)-30.81M
Levered Free Cash Flow (ttm)-14.81M